Back
Anika Therapeutics, Inc. 10K Form
Buy
57
ANIK
Anika Therapeutics, Inc.
Last Price:
$14.19
Seasonality Move:
12.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | ANIK/Anika Therapeutics, Inc. Quarterly |
| 2023-11-03 | 10Q | ANIK/Anika Therapeutics, Inc. Quarterly |
| 2023-08-08 | 10Q | ANIK/Anika Therapeutics, Inc. Quarterly |
| 2023-05-09 | 10Q | ANIK/Anika Therapeutics, Inc. Quarterly |
| 2022-11-09 | 10Q | ANIK/Anika Therapeutics, Inc. Quarterly |
| 2022-08-04 | 10Q | ANIK/Anika Therapeutics, Inc. Quarterly |
Receive ANIK News And Ratings
See the #1 stock for the next 7 days that we like better than ANIK
ANIK Financial Statistics
Sales & Book Value
| Annual Sales: | $119.9M |
|---|---|
| Cash Flow: | $5M |
| Price / Cash Flow: | 284.5 |
| Annual Sales: | $10.18 |
| Price / Book: | 1.26 |
Profitability
| EPS (TTM): | -2.27870 |
|---|---|
| Net Income (TTM): | $-14.3M |
| Gross Margin: | $76M |
| Return on Equity: | -9.18% |
| Return on Assets: | -7.03% |
Anika Therapeutics, Inc. Earnings Forecast
Key Anika Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 32 years for ANIK is 63.38%.
-
The Selling, General & Administrative Expenses for ANIK have been equal to 46.33% of Gross Profit Margin.
-
The Research & Development expenses have been 21.30% of Revenue.
-
The Net Earning history of ANIK is -7.36% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 14 years.
Anika Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ANIK |
| CUSIP: | 035255 |
| Website: | anika.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 5.32 |
| Quick Ratio: | 4.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 36.54 |
ANIK Technical Analysis vs Fundamental Analysis
Buy
57
Anika Therapeutics, Inc. (ANIK)
is a Buy
Is Anika Therapeutics, Inc. a Buy or a Sell?
-
Anika Therapeutics, Inc. stock is rated a BuyThe current Anika Therapeutics, Inc. [ANIK] share price is $12.79. The Score for ANIK is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.